- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/863 - Poxviral vectors, e.g. vaccinia virus
Patent holdings for IPC class C12N 15/863
Total number of patents in this class: 337
10-year publication summary
|
23
|
13
|
20
|
33
|
33
|
19
|
17
|
11
|
21
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bavarian Nordic A/S | 267 |
36 |
| Transgene S.A. | 116 |
16 |
| GeoVax, Inc. | 40 |
13 |
| City of Hope | 1050 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3024 |
7 |
| The Trustees of the University of Pennsylvania | 4444 |
6 |
| Janssen Biotech, Inc. | 1798 |
6 |
| Arizona Board of Regents on behalf of Arizona State University | 3001 |
5 |
| Memorial Sloan-Kettering Cancer Center | 2069 |
5 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3361 |
5 |
| Genvira Biosciences Inc. | 6 |
5 |
| Genelux Corporation | 30 |
4 |
| The Governors of the University of Alberta | 881 |
4 |
| Isis Innovation Limited | 443 |
4 |
| Janssen Vaccines & Prevention B.V. | 263 |
4 |
| Merial, Inc. | 208 |
4 |
| National University Corporation Tottori University | 206 |
4 |
| Vaccinex, Inc. | 117 |
4 |
| Transgene | 20 |
4 |
| Boehringer Ingelheim Animal Health USA Inc. | 415 |
4 |
| Other owners | 189 |